These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36839690)

  • 1. Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines.
    Duarte JA; Gomes ER; De Barros ALB; Leite EA
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
    Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
    Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect.
    Bjørnstad R; Reiten IN; Knudsen KS; Schjøtt J; Herfindal L
    Int J Pharm; 2022 Dec; 629():122379. PubMed ID: 36370997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy.
    Li N; Xie X; Hu Y; He H; Fu X; Fang T; Li C
    Am J Transl Res; 2019; 11(3):1255-1269. PubMed ID: 30972160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer.
    Gomes ER; Carvalho AT; Barbosa TC; Ferreira LL; Calado HDR; Sabino AP; Oliveira MC
    AAPS PharmSciTech; 2022 Sep; 23(7):255. PubMed ID: 36109444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of stealth liposome coencapsulating doxorubicin and fluoxetine.
    Ong JC; Sun F; Chan E
    J Liposome Res; 2011 Dec; 21(4):261-71. PubMed ID: 21226547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
    Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
    J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclareol is a potent enhancer of doxorubicin: Evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer.
    Borges GSM; Silva JO; Fernandes RS; de Souza ÂM; Cassali GD; Yoshida MI; Leite EA; de Barros ALB; Ferreira LAM
    Life Sci; 2019 Sep; 232():116678. PubMed ID: 31344429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.
    Barbălată CI; Porfire AS; Sesarman A; Rauca VF; Banciu M; Muntean D; Știufiuc R; Moldovan A; Moldovan C; Tomuță I
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells.
    Haggag Y; Abu Ras B; El-Tanani Y; Tambuwala MM; McCarron P; Isreb M; El-Tanani M
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1655-1669. PubMed ID: 32841584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin.
    Nguyen PL; Elkamhawy A; Choi YH; Lee CH; Lee K; Cho J
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes.
    Bartkowiak A; Nazaruk E; Gajda E; Godlewska M; Gaweł D; Jabłonowska E; Bilewicz R
    ACS Biomater Sci Eng; 2022 Oct; 8(10):4354-4364. PubMed ID: 36173110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy.
    Gabizon A; Ohana P; Amitay Y; Gorin J; Tzemach D; Mak L; Shmeeda H
    Cancer Drug Resist; 2021; 4(2):463-484. PubMed ID: 35582027
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin.
    Abdullah CS; Ray P; Alam S; Kale N; Aishwarya R; Morshed M; Dutta D; Hudziak C; Banerjee SK; Mallik S; Banerjee S; Bhuiyan MS; Quadir M
    Mol Pharm; 2020 Dec; 17(12):4676-4690. PubMed ID: 33151075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model.
    Franco MS; Roque MC; de Barros ALB; de Oliveira Silva J; Cassali GD; Oliveira MC
    Biomed Pharmacother; 2019 Jan; 109():1728-1739. PubMed ID: 30551427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.